[Chronic mucocutaneous candida mycosis (CMCC) caused by a T-cell defect].
It is reported on a 42-year-old book-keeper with the granulomatous variant of the chronic mucocutaneous candidiasis which could be followed up for 28 years. The intensive systemic treatment with nystatin, 5-fluorocytosin and miconazol combined with the subcutaneous injection of transfer-factor and the local application of ointments containing nystatin and clotrimazol did not only lead to the complete clearing of the lesions (4 years without any relapse), but also to the normalization of the T-lymphocyte count and the reconstitution of the formerly negative delayed type skin reactivity to candidin.
D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D002176:Candida albicans / Q000276:immunology; D002177:Candidiasis / Q000276:immunology*; D002178:Candidiasis, Chronic Mucocutaneous / Q000276:immunology* / Q000628:therapy; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000276:immunology* / Q000628:therapy; D007958:Leukocyte Count; D013601:T-Lymphocytes / Q000276:immunology*; D014165:Transfer Factor / Q000627:therapeutic use
D000935:Antifungal Agents; D014165:Transfer Factor
Chronische mukokutane Candida-Mykose (CMCC) infolge eines T-Zelldefektes.